Brief: Forward Pharma Says European Patent Office Has Revoked EP2801355 Patent
Jan 29 (Reuters) - Forward Pharma A/S FWP.O :
* FORWARD PHARMA ANNOUNCES THE DECISION OF THE EUROPEAN
PATENT
OFFICE IN THE OPPOSITION PROCEEDINGS FOR THE EP2801355 PATENT
* SAYS EUROPEAN PATENT OFFICE HAS REVOKED EP2801355 PATENT
FOLLOWING ORAL HEARING IN OPPOSITION PROCEEDINGS
Source text for Eikon: ID:nGNXOMRZUa
Further company coverage: FWP.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Forward Pharma A/S
See all newsBrief: Forward Pharma- Announces Termination Of Its American Depositary Receipts Facility
U.S. STOCKS ON THE MOVE-Madrigal, Disney, Forward Pharma
Forward Pharma slides to record low on delisting notice from Nasdaq
Brief: Forward Pharma Announces Delisting Its American Depositary Shares From Nasdaq Capital Market
Brief: Forward Pharma A/S Submitted A Request For A Written Decision Regarding Petition For Review Regarding EP2801355 To The EBA